Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 23 Feb 2026 for AN2 Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleSanjay Chanda
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Sanjay Chanda: trading record in brief
Sanjay Chanda appears in our data through filings on AN2 Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 15 March 2024 to 20 February 2026.
Every open-market trade on record is a sale: 2 sales worth €6,685. Besides market trades, the filings include 4 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 23 February 2026, the filings show a share grant in AN2 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sanjay Chanda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
38,000 shares0Common StockSEC:0001193125-26-064141:0
3,295 shares@ US$1.00342.2% of flowCommon StockSEC:0001193125-26-006765:0
50,250 shares0Common StockSEC:0000950170-25-030057:0
2,957 shares@ US$1.34157.8% of flowCommon StockSEC:0000950170-25-003157:0
27,500 shares0Common StockSEC:0001610717-24-000192:0
27,500 shares0Common StockSEC:0001610717-24-000166:0
6 of 5 declarations
